Current clinical guidelines for hyperuricemia and gout emphasize a dual approach: (1) acute flare management using nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, or corticosteroids and (2) long-term urate-lowering therapy (ULT) with xanthine oxidase inhibitors (e.g., allopurinol and febuxostat) or uricosurics (e.g., probenecid) (Karantas et al., 2024
As a board-certified family physician , Ive integrated these therapies into patient care plans with remarkable resultsespecially for individuals dealing with chronic fatigue, injury recovery, stubborn weight, or age-related muscle loss
By leveraging the competition for a more affordable, optimized formulary
Learn more Amino acids, electrolytes and B-vitamins to recover and perform
His choice not to pursue treatment may be misguided, but its his to make, and the condition is unrelated to the gift